Zurn Elkay Water Solutions (ZWS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Net sales grew to $410 million in Q3 2024, up 2.9–4% year-over-year, with core growth across all product categories, partially offset by the planned exit from certain residential sink products.
Adjusted EBITDA reached $105 million (25.6% margin), up 9% year-over-year, with margin expansion of 150 bps, the highest since the Elkay merger.
Free cash flow for Q3 was $87 million, with $50 million deployed for share repurchases and a quarterly dividend raised to $0.09 per share, a 13% increase.
Net income from continuing operations was $43.5–$44 million, with diluted EPS of $0.25 and adjusted EPS of $0.34.
Leverage reached an all-time low of 0.8x net debt, with strong balance sheet flexibility.
Financial highlights
Q3 net sales totaled $410 million, up 2.9–4% year-over-year, with gross profit at $220.6 million and gross margin improvement from cost synergies.
Adjusted EBITDA was $105 million (25.6% margin), with operating income margin up 200 bps year-over-year.
Free cash flow for Q3 was $87 million; year-to-date free cash flow reached $217 million.
Net debt leverage ended at 0.8x, the lowest as a public company.
Cash and cash equivalents stood at $187.9 million as of September 30, 2024.
Outlook and guidance
Full-year adjusted EBITDA expected at $387–$389 million, with margin expansion of 250–270 bps year-over-year.
Full-year free cash flow outlook raised to approximately $260 million.
Q4 2024 core sales growth projected in the low single digits; adjusted EBITDA expected between $88–$90 million.
Price increases of 1–2% anticipated in 2025 as demand recovers.
Management expects continued restructuring to optimize margin and footprint, with further expenses for workforce reductions and facility rationalization.
Latest events from Zurn Elkay Water Solutions
- Q2 2026 saw double-digit sales growth, record margins, and a raised full-year outlook.ZWS
Q2 2026 - Q1 2026 saw 11% sales growth, 18% higher adjusted EBITDA, and $50M in share repurchases.ZWS
Q1 2026 - Annual Meeting to address director elections, executive pay, and auditor ratification.ZWS
Proxy filing - Strong 2025 results, board refreshment, and robust ESG drive positive outlook.ZWS
Proxy filing - Record 2025 results with strong growth, margin expansion, and robust 2026 outlook.ZWS
Q4 2025 - Q2 2025 saw 8% sales growth, record margin, and strong cash flow, prompting a raised outlook.ZWS
Q2 2025 - Q2 2024 delivered record margins, strong cash flow, and raised full-year guidance.ZWS
Q2 2024 - Q1 2025 delivered 5% core sales growth, 110 bps margin expansion, and $77M in share repurchases.ZWS
Q1 2025 - Record sales, margin expansion, and strong cash flow set the stage for continued growth.ZWS
Q4 2024